Clinical Trial: A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Two GSK3862995B Formulations in Healthy Participants

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789899) titled 'A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Two GSK3862995B Formulations in Healthy Participants' on Aug. 24.

Brief Summary: This study will compare two formulations of the investigational medicine GSK3862995B in healthy adults. The study aims to assess how the body absorbs and processes the medicine, and to evaluate its safety and tolerability.

Study Start Date: Aug. 24

Study Type: INTERVENTIONAL

Condition: Pulmonary Disease, Chronic Obstructive

Intervention: DRUG: GSK3862995B

GSK3862995B will be administered.

Recruitment Status: RECRUITING

Sponsor: GlaxoSmithKline

Disclaimer: Curated by HT Syndicati...